<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-7944553634888906866</id><updated>2024-09-21T13:28:15.030-07:00</updated><category term="colon cancer"/><category term="PSA test"/><category term="prostate cancer"/><category term="Hormones prostate"/><category term="PC SPES"/><category term="bicalutamide"/><category term="black prostate"/><category term="bladder"/><category term="bleeding"/><category term="bloody urine"/><category term="cryotherapy"/><category term="depression"/><category term="erectile dysfunction"/><category term="fecal DNA tests"/><category term="flutamide"/><category term="gleason score"/><category term="herbs for prostate cancer"/><category term="impotence"/><category term="liver"/><category term="lung cancer"/><category term="nilutamde"/><category term="orchidectomy"/><category term="prognosis prostate"/><category term="prostate"/><category term="prostate antigen"/><category term="prostate biopsy"/><category term="prostate brachytherapy"/><category term="prostate cancer symptoms"/><category term="prostate exam"/><category term="prostate malignancy"/><category term="prostatectomy"/><category term="radiation prostate"/><category term="rectal exam"/><category term="risks prostate cancer"/><category term="shark cartilage"/><category term="treat prostate cancer"/><category term="urination"/><category term="vasectomy"/><title type='text'>Everything Cancer</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>18</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-7182795395030446791</id><published>2011-03-26T03:18:00.001-07:00</published><updated>2011-03-26T03:18:51.660-07:00</updated><title type='text'>Rich White Women are more prone to developing the deadly melanoma</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-line-height-alt: 14.65pt;&quot;&gt;&lt;span style=&quot;color: black; font-size: 16.0pt; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-US;&quot;&gt;Current evidence shows that rich white &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexwomen.blogspot.com/&quot;&gt;women&lt;/a&gt;&lt;/b&gt; are more prone to the deadly &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexskin.blogspot.com/&quot;&gt;skin&lt;/a&gt;&lt;/b&gt; cancer melanoma compared to other women. Researchers looked at thousands of women who were diagnosed with melanomas and found that one common factor was that these were rich, well-educated Caucasian females. The increase in melanomas was most likely because these affluent women had&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;spent a lot of time tanning and/or enjoying long vacations in sunny areas throughout the year. So if you are rich, Caucasian and love the sun- do not say you have not been warned, Wear a sunscreen and protect your &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexskin.blogspot.com/&quot;&gt;skin&lt;/a&gt;&lt;/b&gt;. Melanoma is among the worst type of &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexcan.blogspot.com/&quot;&gt;cancer&lt;/a&gt; &lt;/b&gt;you can get.&lt;/span&gt;&lt;span style=&quot;color: black; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-US;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/7182795395030446791/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2011/03/rich-white-women-are-more-prone-to.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7182795395030446791'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7182795395030446791'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2011/03/rich-white-women-are-more-prone-to.html' title='Rich White Women are more prone to developing the deadly melanoma'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-3120999284681123528</id><published>2011-01-29T10:08:00.001-08:00</published><updated>2011-01-29T10:08:08.117-08:00</updated><title type='text'>Can green tea prevent cancer?</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span class=&quot;apple-style-span&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 14.0pt; mso-themecolor: text1;&quot;&gt;Almost every week, a new disease is supposedly cured or prevented by &lt;a href=&quot;http://www.sbmedexherbs.blogspot.com/&quot;&gt;green tea&lt;/a&gt;. Millions of people drink green tea because they believe it has some type of miraculous healing powers. Therefore, the question is, “can green tea &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexprev.blogspot.com/&quot;&gt;prevent&lt;/a&gt; &lt;/b&gt;cancer?”&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span class=&quot;apple-style-span&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 14.0pt; mso-themecolor: text1;&quot;&gt;A few reputable studies in the English literature have looked at the effects of &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexherbs.blogspot.com/&quot;&gt;green tea&lt;/a&gt;&lt;/b&gt; as an aid in preventing cancer. The conclusion was simple- it does diddlysquat. &lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp;&lt;/span&gt;Chinese people have been drinking green tea for centuries, and yet millions of &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexchina.blogspot.com/&quot;&gt;Chinese&lt;/a&gt; &lt;/b&gt;die from a variety of cancers. Green tea is nothing more than a social beverage- it has zero cancer &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexprev.blogspot.com/&quot;&gt;preventive&lt;/a&gt;&lt;/b&gt; actions. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span class=&quot;apple-style-span&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 14.0pt; mso-themecolor: text1;&quot;&gt;The only good thing about green tea is that it has no harmful effects even if you drink and shower with it every day. The only people who benefit from &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexherbs.blogspot.com/&quot;&gt;green tea&lt;/a&gt;&lt;/b&gt; are the people who sell this bland beverage at exorbitant prices. If you want to prevent cancer, eat healthy, &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexsport.blogspot.com/&quot;&gt;exercise,&lt;/a&gt;&lt;/b&gt; do not &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexsmoke.blogspot.com/&quot;&gt;smoke&lt;/a&gt;&lt;/b&gt; and leave the rest to fate- stop wasting your hard-earned money listening to &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexsuck.blogspot.com/&quot;&gt;charlatans&lt;/a&gt;&lt;/b&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/3120999284681123528/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2011/01/can-green-tea-prevent-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3120999284681123528'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3120999284681123528'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2011/01/can-green-tea-prevent-cancer.html' title='Can green tea prevent cancer?'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-7993937904732611555</id><published>2010-12-24T15:58:00.001-08:00</published><updated>2010-12-24T15:58:50.809-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="colon cancer"/><category scheme="http://www.blogger.com/atom/ns#" term="liver"/><title type='text'>My father has just found out that he has colon cancer which has spread to the liver and is not operable. What else can he be offered in terms of therapy?</title><content type='html'>&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt; mso-bidi-font-family: Arial;&quot;&gt;Unfortunately, the choices for your father are very limited. For &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexcolon.blogspot.com/&quot;&gt;colon&lt;/a&gt;&lt;/b&gt; cancer which has spread to the &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexliver.blogspot.com/&quot;&gt;liver&lt;/a&gt;&lt;/b&gt;, the prognosis is very poor.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt; mso-bidi-font-family: Arial;&quot;&gt;Perhaps you should speak to your doctor about hospice or palliative care. At this stage, most doctors only treat the &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexpain.blogspot.com/&quot;&gt;pain&lt;/a&gt;&lt;/b&gt; and try to make life comfortable.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt; mso-bidi-font-family: Arial;&quot;&gt;The reality is that once &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexcolon.blogspot.com/&quot;&gt;colon&lt;/a&gt; &lt;/b&gt;cancer spreads, all treatments are futile. Life expectancy is short. Do not waste your hard earned money on charlatans who make false promises.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt; mso-bidi-font-family: Arial;&quot;&gt;Take each day as it comes and enjoy whatever days you have remaining with him.&lt;/span&gt;&lt;span style=&quot;color: #bf005f; font-family: Arial; font-size: 14.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/7993937904732611555/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2010/12/my-father-has-just-found-out-that-he.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7993937904732611555'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7993937904732611555'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2010/12/my-father-has-just-found-out-that-he.html' title='My father has just found out that he has colon cancer which has spread to the liver and is not operable. What else can he be offered in terms of therapy?'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-7005890502171611936</id><published>2010-12-24T15:54:00.000-08:00</published><updated>2010-12-24T16:32:06.306-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="bleeding"/><category scheme="http://www.blogger.com/atom/ns#" term="colon cancer"/><title type='text'>I am a 27 year old male and noticed some blood in my stools. I am scared of developing cancer?</title><content type='html'>&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt;&quot;&gt;Do not worry; &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexcolon.blogspot.com/&quot;&gt;colon&lt;/a&gt;&lt;/b&gt; cancer is a disease of older people. &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexblood.blogspot.com/&quot;&gt;Blood&lt;/a&gt;&lt;/b&gt; in the stools in young people can be from hemorrhoids, rectal tears or &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexanus.blogspot.com/&quot;&gt;anal&lt;/a&gt;&lt;/b&gt; fissures.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt;&quot;&gt;&lt;st1:city w:st=&quot;on&quot;&gt;&lt;st1:place w:st=&quot;on&quot;&gt;Colon&lt;/st1:place&gt;&lt;/st1:city&gt; cancer under the age of 50 is quite rare. Unless you have a family history, the risk of &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexcolon.blogspot.com/&quot;&gt;colon&lt;/a&gt;&lt;/b&gt; cancer is very small. In your case, the bleeding may be related to something near the &lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;a href=&quot;http://www.sbmedexanus.blogspot.com/&quot;&gt;rectum&lt;/a&gt;&lt;/b&gt;.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;margin-bottom: 3.75pt; margin-left: 0cm; margin-right: 0cm; margin-top: 3.75pt;&quot;&gt;&lt;span style=&quot;color: black; font-family: Verdana; font-size: 14.5pt;&quot;&gt;If the bleeding does not happen again, I would not worry about it. But if the bleeding persists then a visit to the doctor is recommended&lt;/span&gt;&lt;span style=&quot;color: #bf005f; font-family: Arial; font-size: 14.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/7005890502171611936/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2010/12/i-am-27-year-old-male-and-notched-some.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7005890502171611936'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7005890502171611936'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2010/12/i-am-27-year-old-male-and-notched-some.html' title='I am a 27 year old male and noticed some blood in my stools. I am scared of developing cancer?'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-2605668160998203289</id><published>2010-11-17T17:00:00.000-08:00</published><updated>2010-11-17T17:00:05.874-08:00</updated><title type='text'>Mammograms have very low risk of radiation</title><content type='html'>&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;    &lt;m:brkBin m:val=&quot;before&quot;/&gt;    &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;    &lt;m:smallFrac m:val=&quot;off&quot;/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val=&quot;0&quot;/&gt;    &lt;m:rMargin m:val=&quot;0&quot;/&gt;    &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;    &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;    &lt;m:intLim m:val=&quot;subSup&quot;/&gt;    &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;footer&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;page number&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;Hyperlink&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:&quot;Table Normal&quot;;
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;A new study from Canada suggests that the potential &lt;b&gt;&lt;a href=&quot;http://www.sbmedexcancer.blogspot.com/&quot;&gt;cancer&lt;/a&gt;&lt;/b&gt; risk from radiation during a mammogram is very small compared to the benefits of lives saved from early detection of the &lt;b&gt;&lt;a href=&quot;http://www.sbmedexbreast.blogspot.com/&quot;&gt;breast&lt;/a&gt;&lt;/b&gt; cancer.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;Said &lt;span&gt;&amp;nbsp;&lt;/span&gt;Martin Yafee researcher at Sunnybrook hospital in Toronto, “This risk of radiation-induced &lt;a href=&quot;http://news.yahoo.com/s/hsn/20101117/hl_hsn/cancerriskfromradiationofmammogramsisslightstudy;_ylt=AvtfIf5ekQPlcr.UOw8YJhgUewgF;_ylu=X3oDMTRiczY1NW91BGFzc2V0Ay9zL2hzbi8yMDEwMTExNy9obF9oc24vY2FuY2Vycmlza2Zyb21yYWRpYXRpb25vZm1hbW1vZ3JhbXNpc3NsaWdodHN0dWR5BGNjb2RlA2NlYm5iZQRjcG9zAzEEcG9zAzEEc2VjA3luX3RvcF9zdG9yaWVzBHNsawNjYW5jZXJyaXNrZnI-&quot; id=&quot;KonaLink0&quot; target=&quot;undefined&quot;&gt;&lt;span class=&quot;klink&quot;&gt;&lt;span style=&quot;color: black; text-decoration: none;&quot;&gt;breast cancers&lt;/span&gt;&lt;/span&gt;&lt;/a&gt; is mentioned periodically by women and people who are critiquing screening [and how often it should be done and in whom.”&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;Added Dr Arnold Rotter from the radiology department at City of Hope Cancer center in Duarte, CA, &quot;This study says that the good obtained from having a screening mammogram far exceeds the risk you might have from the radiation received from the low-dose mammogram,&quot; &lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;Dr Yaffe and his team &lt;span&gt;&amp;nbsp;&lt;/span&gt;developed a mathematical model to estimate the risk of radiation-induced &lt;/span&gt;&lt;span class=&quot;klink&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&lt;a href=&quot;http://www.sbmedexbreast.blogspot.com/&quot; id=&quot;KonaLink1&quot;&gt;breast&lt;/a&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class=&quot;klink&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt; cancer&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt; following exposure to radiation from mammograms, and then estimated the number of breast cancers, fatal breast cancers and years of life lost attributable to the mammography&#39;s screening radiation. They applied this model to hypothetical data from women who undergo mammograms.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;What they found: If 100,000 women got annual mammograms from ages 40 to 55 and then got mammograms every other year until age 74, 86 breast cancers and 11 deaths would be attributable to the mammography radiation.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;Simply put another way, Jaffe said: &quot;Your chances are one in 1,000 of developing a breast cancer from the radiation. Your chances of dying are one in 10,000. But the &lt;a href=&quot;http://news.yahoo.com/s/hsn/20101117/hl_hsn/cancerriskfromradiationofmammogramsisslightstudy;_ylt=AvtfIf5ekQPlcr.UOw8YJhgUewgF;_ylu=X3oDMTRiczY1NW91BGFzc2V0Ay9zL2hzbi8yMDEwMTExNy9obF9oc24vY2FuY2Vycmlza2Zyb21yYWRpYXRpb25vZm1hbW1vZ3JhbXNpc3NsaWdodHN0dWR5BGNjb2RlA2NlYm5iZQRjcG9zAzEEcG9zAzEEc2VjA3luX3RvcF9zdG9yaWVzBHNsawNjYW5jZXJyaXNrZnI-&quot; id=&quot;KonaLink3&quot; target=&quot;undefined&quot;&gt;&lt;span class=&quot;klink&quot;&gt;&lt;span style=&quot;color: black; text-decoration: none;&quot;&gt;lifetime risk&lt;/span&gt;&lt;/span&gt;&lt;/a&gt; of breast cancer is estimated at about one in eight or nine.” he added.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&quot;I&#39;m not minimizing the concern of radiation,&quot; Rotter said. &quot;Everything is a balance.&quot; For example, younger breasts, particularly those of women aged 40 to 49, are more sensitive to radiation than &lt;b&gt;&lt;a href=&quot;http://www.sbmedexbreast.blogspot.com/&quot;&gt;breasts&lt;/a&gt;&lt;/b&gt; in older women, but the new study shows it&#39;s better to get the screening mammography than skip it.&lt;/span&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/2605668160998203289/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2010/11/mammograms-have-very-low-risk-of.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/2605668160998203289'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/2605668160998203289'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2010/11/mammograms-have-very-low-risk-of.html' title='Mammograms have very low risk of radiation'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-2142377966989429449</id><published>2010-11-17T16:53:00.000-08:00</published><updated>2010-11-17T16:53:45.758-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="lung cancer"/><title type='text'>Elderly can undergo aggressive lung cancer treatments</title><content type='html'>&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;    &lt;m:brkBin m:val=&quot;before&quot;/&gt;    &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;    &lt;m:smallFrac m:val=&quot;off&quot;/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val=&quot;0&quot;/&gt;    &lt;m:rMargin m:val=&quot;0&quot;/&gt;    &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;    &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;    &lt;m:intLim m:val=&quot;subSup&quot;/&gt;    &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;footer&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;page number&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;Hyperlink&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:&quot;Table Normal&quot;;
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;br /&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;    &lt;m:brkBin m:val=&quot;before&quot;/&gt;    &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;    &lt;m:smallFrac m:val=&quot;off&quot;/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val=&quot;0&quot;/&gt;    &lt;m:rMargin m:val=&quot;0&quot;/&gt;    &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;    &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;    &lt;m:intLim m:val=&quot;subSup&quot;/&gt;    &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;footer&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;page number&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;Hyperlink&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;   &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:&quot;Table Normal&quot;;
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;div class=&quot;MsoNormal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;For many years, the trend in North America has been to treat elderly people who have lung &lt;b&gt;&lt;a href=&quot;http://www.sbmedexcancer.blogspot.com/&quot;&gt;cancer&lt;/a&gt;&lt;/b&gt; with conservative chemotherapy. The reason for this is that it was always felt that the elderly were fragile and would not be able to tolerate the harsh chemotherapeutic &lt;b&gt;&lt;a href=&quot;http://www.sbmedexdrugs.blogspot.com/&quot;&gt;drugs&lt;/a&gt;&lt;/b&gt;. Well, now a major study indicates that this thinking is wrong. A recent study from France reveals that elderly patients lived longer, cancer free and had a decent quality of life after aggressive chemotherapy.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;&quot;These results demonstrate that a more intensive regimen given to younger patients can be effective and tolerable in this (elderly) group,&quot; said lead researcher Dr. Elisabeth Quoix&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;Younger patients with&lt;b&gt;&lt;a href=&quot;http://www.sbmedexlung.blogspot.com/&quot;&gt; lung&lt;/a&gt;&lt;/b&gt; cancer have always been offered a combination of drugs but elderly have in the past only been offered one drug. This was chiefly because of physicians fear that the elderly may not tolerate the side effects well.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;Researchers in France looked at 451 patients between the age of 70- 89 and offered them single or multiple chemotherapeutic drugs for their &lt;b&gt;&lt;a href=&quot;http://www.sbmedexlung.blogspot.com/&quot;&gt;lung&lt;/a&gt; &lt;/b&gt;cancer. The study had to be stopped because the researchers observed that the overall survival period for patients given the combination chemotherapy was 10.4 months compared to 6.2 months for those getting only one drug. They also noticed that patients receiving two &lt;b&gt;&lt;a href=&quot;http://www.sbmedexcancer.blogspot.com/&quot;&gt;cancer&lt;/a&gt; &lt;/b&gt;drugs lived twice as long and the side effects were easily tolerated.&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;Dr. Mark Kris, chief of thoracic oncology at Memorial-Sloan Kettering Hospital in New York and ASCO representative, said that the impact of this trial is &lt;span&gt;&amp;nbsp;&lt;/span&gt;&quot;huge.&quot;&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;Kris says &quot;the message of this paper is really important&quot; because it encourages oncologists to look beyond their patient&#39;s chronological age and if the patient is fit enough, doctors should have the &quot;confidence to give the best treatment available to older adults with the anticipation of getting the same benefits and side effects.&quot;&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 12pt; line-height: 115%;&quot;&gt;Kris said, &quot;Of all the trials, this one is the one with the most immediate impact&quot; because doctors and patients can take this information and use it next week. &lt;/span&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/2142377966989429449/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2010/11/elderly-can-undergo-aggressive-lung.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/2142377966989429449'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/2142377966989429449'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2010/11/elderly-can-undergo-aggressive-lung.html' title='Elderly can undergo aggressive lung cancer treatments'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-1844224718386957153</id><published>2009-03-31T04:32:00.001-07:00</published><updated>2009-03-31T04:38:36.446-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="colon cancer"/><category scheme="http://www.blogger.com/atom/ns#" term="fecal DNA tests"/><title type='text'>Fecal DNA tests for colon cancer</title><content type='html'>Colon cancer is the 2nd leading cause of cancer deaths in North America. So far nothing we have done in terms of prevention has helped decrease the rates of colon cancer. The only way to improve mortality is to make a diagnosis of the cancer early. We do have many screening tests for colon cancer, but tests like colonoscopy and virtual colonoscopy are expensive. The Fecal occult blood test is not very specific. &lt;br /&gt;&lt;br /&gt;In the last few years, scientists have developed Fecal DNA tests. The first generation of these tests were not great. For example, the tests would repeatedly show that you have a cancer, when in fact you did not have a cancer (false positives). Further, the tests also sometimes showed that one did not have a cancer, when in fact a cancer was present (false negative). However, the latest generation of DNA tests have been improved but they are not 100 percent sensitive or specific.&lt;br /&gt;&lt;br /&gt;The tests involving sampling stool for DNA. A colon cancer if present anywhere in the colon can be identified roughly 88% of the time.&lt;br /&gt;&lt;br /&gt;The Fecal DNA kits appear to be slightly better than the &lt;a href=&quot;www.medexsupply.com&quot;&gt;fecal occult blood test kits &lt;/a&gt;(FOBT) at detecting colon cancer. &lt;br /&gt;&lt;br /&gt;For the time being, anyone over the age of 50, should continue with a reliable screening test for colon cancer. The fecal DNA tests will most likely be improved in the future but for the time being, the &lt;a href=&quot;www.medexsupply.com&quot;&gt;fecal occult blood test&lt;/a&gt; should not be chucked away. Cost is another issue. The &lt;a href=&quot;www.medexsupply.com&quot;&gt;Fecal occult blood tests&lt;/a&gt; can cost anywhere from $3-$25, while the DNA kits costs anywhere from $500-$1,000. Another big difference is that the FOBT only requires a stool smear; the DNA kits require collecting a whole bucket of stools.&lt;br /&gt;&lt;br /&gt;And finally, the majority of insurance carriers do not cover costs of the Fecal DNA test. For the time being and for those who can afford it, &lt;span style=&quot;font-weight:bold;&quot;&gt;Colonoscopy&lt;/span&gt; is still the &lt;span style=&quot;font-weight:bold;&quot;&gt;gold standard&lt;/span&gt; screening test for colon cancer.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/1844224718386957153/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/03/fecal-dna-tests-for-colon-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/1844224718386957153'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/1844224718386957153'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/03/fecal-dna-tests-for-colon-cancer.html' title='Fecal DNA tests for colon cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-3790381692819955094</id><published>2009-02-19T20:21:00.000-08:00</published><updated>2009-02-19T20:23:12.437-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="herbs for prostate cancer"/><category scheme="http://www.blogger.com/atom/ns#" term="PC SPES"/><category scheme="http://www.blogger.com/atom/ns#" term="shark cartilage"/><title type='text'>Other Treatments for Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Coping skills:&lt;/span&gt; Once a diagnosis of prostate cancer is made, the news is always devastating and depressing. Many individuals may not be able to cope with such news. To cope with a prostate cancer, the best way is to educate oneself. One should maintain a normal routine of lifestyle and work. One should not suffer the burden of a cancer diagnosis on their own and seek counseling from family members friends and help is even available by calling the National Cancer Organization(s). The best way to deal with the cancer is by being well informed with the cancer.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Alternative medicine:&lt;/span&gt; Like everything in medicine, alternative medicine is fast catching on as a treatment for all cancers. This is mainly because of the &lt;span style=&quot;font-weight:bold;&quot;&gt;dissatisfaction&lt;/span&gt; of individuals with conventional medicine. &lt;br /&gt;&lt;br /&gt;There are numerous nutrition supplements and herbs which are found in every store all over the country- all of them claiming great success in treating prostate disease and cure all other cancers. Most of the success of these products is claimed by the industry and the manufacturers.The question remains, are these therapies effective? &lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Anecdotal data &lt;/span&gt;always suggests that these products are effective but no large controlled trials are available on the majority of these products. Even though these products are widely used, there is absolutely no regulation or control of these products. The ingredients, their content or their purity is not assessed and their long term safety remains unknown. In addition, fake supplements are on the increase and buyer better beware.Herbal Supplements: There are a number of nutritional herbs claiming to be effective in the treatment of prostate cancer but there is not an iota of medical evidence that any of these substances work. &lt;br /&gt;&lt;br /&gt;The herbs postulated to have activity against prostate cancer include &lt;span style=&quot;font-weight:bold;&quot;&gt;chaparral, PC SPES and shark cartilage.&lt;/span&gt; The majority of these products have not been shown to have any benefit in humans and yet they are sold in all herbal stores.&lt;br /&gt;&lt;br /&gt;Because it&#39;s not always easy to tell which products may be unsafe, the best advice is to seek speak to your physician. These products are by &lt;span style=&quot;font-weight:bold;&quot;&gt;no means cheap&lt;/span&gt; and by having &lt;span style=&quot;font-weight:bold;&quot;&gt;blind faith&lt;/span&gt; in these products, one not only tends to lose their money but also their life.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/3790381692819955094/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/other-treatments-for-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3790381692819955094'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3790381692819955094'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/other-treatments-for-prostate-cancer.html' title='Other Treatments for Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-6705742027234140780</id><published>2009-02-19T20:19:00.000-08:00</published><updated>2009-02-19T20:21:00.221-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="cryotherapy"/><category scheme="http://www.blogger.com/atom/ns#" term="treat prostate cancer"/><title type='text'>More Treatments for Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Cryotherapy:&lt;/span&gt; Cryotherapy involves use of freezing temperatures to destroy the cancer cells. Cryotherapy has been used to treat prostate cancer in the past. It involves the use of a probe placed through the rectum and freezes the prostate. &lt;br /&gt;&lt;br /&gt;The &lt;span style=&quot;font-weight:bold;&quot;&gt;freezing action&lt;/span&gt; destroys the cancer cells. However, previous results were poor and associated with a number of complications including damage to surrounding structures such as the bladder and rectum. Bladder incontinence was a major complication of Cryotherapy.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Observation:&lt;/span&gt; The PSA blood test can help detect prostate cancer at a very early stage. This allows many men to choose observation as a treatment option. With observation, one has to have regular follow-ups, frequent blood tests, repeat rectal exams and possibly biopsies to monitor the progression of the early cancer.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Prevention:&lt;/span&gt; Unfortunately prostate cancer can’t be prevented but one can take measures to decrease the risks or slow its progression. The most important steps one can take to maintain good health is to well, be physically active and get regular check up from the doctor.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/6705742027234140780/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/more-treatments-for-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6705742027234140780'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6705742027234140780'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/more-treatments-for-prostate-cancer.html' title='More Treatments for Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-5791485201112910811</id><published>2009-02-19T20:17:00.000-08:00</published><updated>2009-02-19T20:18:19.145-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="orchidectomy"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate"/><category scheme="http://www.blogger.com/atom/ns#" term="prostatectomy"/><title type='text'>Additional Treatments for Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Orchidectomy:&lt;/span&gt; A few men elect to undergo an orchidectomy. The testes are a major source of testosterone and surgical removal of the testes eliminates the hormone. This mode of therapy is usually for individuals with advanced prostate cancer and is quite effective. The procedure is not as painful as it sounds. The surgery is done under general/local anesthesia and takes 30-45 minutes. Most patients are discharged home the same day.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Radical prostatectomy:&lt;/span&gt; Surgical removal of the prostate gland is another option for patients with prostate cancer. This is a major surgical procedure which removes the entire prostate and adjacent lymph nodes. The surgeon tries to preserve the nerves and muscles which control urination and sexual function. Both have been designed to prevent the complication to the adjacent organs, however, a fair number of individuals continue to have complications. Complications of surgery include impotence and urinary incontinence.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Chemotherapy:&lt;/span&gt; Chemotherapy drugs are frequently used to treat prostate cancer. These toxic drugs kill the rapidly growing cancer cells. This form of therapy is not curative but can help control the spread. However, chemotherapy is associated with more side effects and is generally given to men who have prostate cancer which did not respond to hormonal therapy. Today, various combinations of chemotherapeutic drugs are used and may even be combined with hormones. Early results are positive but long term resulting are not available.&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;br /&gt;Future therapy:&lt;/span&gt; Current trials are evaluating use of stem cells, gene therapy and immune therapy in the treatment of prostate cancer which has already spread.  These newer treatments are currently only available at major cancer centers.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/5791485201112910811/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/additional-treatments-for-prostate.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/5791485201112910811'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/5791485201112910811'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/additional-treatments-for-prostate.html' title='Additional Treatments for Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-199324062339839521</id><published>2009-02-19T16:10:00.000-08:00</published><updated>2009-02-19T16:13:45.547-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="bicalutamide"/><category scheme="http://www.blogger.com/atom/ns#" term="flutamide"/><category scheme="http://www.blogger.com/atom/ns#" term="Hormones prostate"/><category scheme="http://www.blogger.com/atom/ns#" term="nilutamde"/><title type='text'>Hormone Treatment for Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Hormone therapy:&lt;/span&gt; Because testosterone is known to stimulate growth of prostate cancer cells, anti hormonal therapy is frequently used to treat prostate cancer. Hormone therapy either uses drugs to stop the production of the male sex hormones or the entire source of the hormone is surgically stopped by removing the testicle (orchidectomy). &lt;br /&gt;&lt;br /&gt;Occasionally, both types of treatment are used.Hormonal therapy is most effective in men with advanced prostate cancer. The treatment does help to slow the growth and frequently shrinks the tumor. Because this therapy is effective in shrinking tumors, hormonal therapy is frequently used in the early stage of prostate cancer — often in combination with radiation and surgery. &lt;br /&gt;&lt;br /&gt;Once the tumor size is downsized, surgery or radiation therapy can be used to destroy whatever tumor is left behind. Also available are drugs which prevent the release of signals from the brain to manufacture testosterone (&lt;span style=&quot;font-weight:bold;&quot;&gt;LH-RH agonists)&lt;/span&gt;. These longer acting drugs are injected every 2-3 months. The drugs can be continued for a prolonged time without undue side effects.&lt;br /&gt;&lt;br /&gt;In the past decade, other &lt;span style=&quot;font-weight:bold;&quot;&gt;anti testosterone drugs&lt;/span&gt; have become available in the treatment of prostate cancer. These medications include flutamide (Eulexin), bicalutamide (Casodex) and nilutamide (Nilandron). They can be taken orally and can be combined with LH-RH agonists.&lt;br /&gt;&lt;br /&gt;Drug therapy, however, is &lt;span style=&quot;font-weight:bold;&quot;&gt;not ideal&lt;/span&gt; for the treatment of prostate cancer. After a few years, most cancer cells develop mechanisms to resist these drugs and develop alternative mechanisms for survival. To prevent the development of drug resistance, intermittent hormone therapy programs have been developed. The PSA levels are monitored and once the levels start to drop, the drugs are stopped. If the PSA levels rise, the drugs are re-started again.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/199324062339839521/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/hormone-treatment-for-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/199324062339839521'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/199324062339839521'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/hormone-treatment-for-prostate-cancer.html' title='Hormone Treatment for Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-6515432942732516949</id><published>2009-02-19T16:08:00.000-08:00</published><updated>2009-02-19T16:10:54.980-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="prostate brachytherapy"/><category scheme="http://www.blogger.com/atom/ns#" term="radiation prostate"/><title type='text'>Radiation for Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Prostate cancer&lt;/span&gt; can be treated in more than one way. Depending on the rate of growth, age, life expectancy, stage and spread, combination therapy is often used. The most common treatments for prostate cancer include the following:&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;br /&gt;Radiation:&lt;/span&gt; One may either receive direct radiation therapy to the prostate or the surgeon may place small radioactive implants in the prostate. They both work by killing the cancer cells. Today, radiation therapy is applied in a very sophisticated way to prevent toxicity.  &lt;br /&gt;&lt;br /&gt;With precise focusing of radiation beams, greater doses of radiation can be given to decrease the frequency of complications. During the radiation therapy, all individuals are protected by custom-designed shields. &lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Radiation treatments&lt;/span&gt; are generally given over a 6-8 week period. Radioactive seed implants: Another radiation option is to implant radioactive seeds into the prostate gland. Implantation of these seeds is also known as &lt;span style=&quot;font-weight:bold;&quot;&gt;brachytherapy&lt;/span&gt;. Unlike external beam radiation, these implanted seeds deliver a higher dose of localized radiation than do external beams over a much longer period of time. &lt;br /&gt;&lt;br /&gt;The implantation of these radioactive seeds &lt;span style=&quot;font-weight:bold;&quot;&gt;requires surgery&lt;/span&gt; under general anesthesia and takes about 1-3 hours. This therapy is generally used in men with small to moderate size low grade prostate cancers. Because the radiation exposure is limited to the prostate, there is no risk to others.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/6515432942732516949/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/radiation-for-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6515432942732516949'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6515432942732516949'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/radiation-for-prostate-cancer.html' title='Radiation for Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-7253175202124176053</id><published>2009-02-19T15:05:00.000-08:00</published><updated>2009-02-19T15:07:29.322-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="depression"/><category scheme="http://www.blogger.com/atom/ns#" term="erectile dysfunction"/><category scheme="http://www.blogger.com/atom/ns#" term="impotence"/><category scheme="http://www.blogger.com/atom/ns#" term="prognosis prostate"/><title type='text'>Prognosis of prostate cancer</title><content type='html'>When prostate cancer is not treated, a whole host of &lt;span style=&quot;font-weight:bold;&quot;&gt;complications&lt;/span&gt; can occur. The typical complications of untreated prostate cancer include:&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Spread of cancer:&lt;/span&gt; Prostate cancer can spread to nearby organs and bones and can be life-threatening.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Pain&lt;/span&gt;: Although early-stage prostate cancer typically isn&#39;t painful, once it spreads to bones, it may produce severe pain. In most cases the pain is severe and requires some form of treatment. These treatments may include hormonal therapy, radiation therapy or chemotherapy. If these treatments aren&#39;t successful in relieving pain, a pain management consult is required. In most cases, narcotics are required to relieve the pain.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Urinary incontinence&lt;/span&gt;: Prostate cancer can cause varying degrees of incontinence. Treatments may include behavior modifications, exercises to strengthen pelvic muscles (Kegel exercises), drugs and catheters. If the above fail, complex surgery is required with no guarantee that it will work.&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;br /&gt;- Erectile dysfunction &lt;/span&gt;(ED) or impotence: Like incontinence, ED can be a result of prostate cancer. Various drugs and mechanical devices are available that may assist in achieving an erection. Current drugs include Sildenafil (&lt;span style=&quot;font-weight:bold;&quot;&gt;Viagra&lt;/span&gt;), &lt;span style=&quot;font-weight:bold;&quot;&gt;tadalafil&lt;/span&gt; (Cialis) and &lt;span style=&quot;font-weight:bold;&quot;&gt;vardenafil &lt;/span&gt;(Levitra). When all these fail, surgical penile implant is the last resort to help achieve an erection.&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;br /&gt;- Depression&lt;/span&gt;. Whenever a diagnosis of cancer is made, it is natural for all individuals to develop depression. The severity and duration of depression may determine the treatment. When depression affects one’s ability to manage life and family, treatment is recommended. Treatment may involve psychological counseling or drug therapy. In many cases, a combination of the two therapies often is successful.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/7253175202124176053/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/prognosis-of-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7253175202124176053'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7253175202124176053'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/prognosis-of-prostate-cancer.html' title='Prognosis of prostate cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-3375717584933337991</id><published>2009-02-19T15:03:00.000-08:00</published><updated>2009-02-19T15:05:12.509-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="gleason score"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate cancer"/><title type='text'>Grading of Prostate Cancer</title><content type='html'>Once &lt;span style=&quot;font-weight:bold;&quot;&gt;prostate cancer&lt;/span&gt; has been diagnosed, further testing is done to determine if spread has occurred. The majority of men do not require these additional investigations if no other symptoms are present. &lt;span style=&quot;font-weight:bold;&quot;&gt;Treatment&lt;/span&gt; of the prostate cancer is then based on the &lt;span style=&quot;font-weight:bold;&quot;&gt;needle biopsy results.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Test to determine spread of cancer are all radiological and may include a bone scan, Ultrasound, CT or MRI. Sometimes biopsy of the lymph nodes in the pelvis is required to determine if they are cancerous.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Grading&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Whenever a cancer is diagnosed, the next step is to define the &lt;span style=&quot;font-weight:bold;&quot;&gt;grade&lt;/span&gt;-which allows one to determine it aggressiveness. The degree of aggressiveness can be evaluated by looking at the degree of differentiation of the prostate cells. &lt;br /&gt;&lt;br /&gt;The &lt;span style=&quot;font-weight:bold;&quot;&gt;degree of differentiation&lt;/span&gt; is then graded. With prostate cancer, a grading scale known as the Gleason score is used to define the degree of differentiation. The &lt;span style=&quot;font-weight:bold;&quot;&gt;Gleason grading&lt;/span&gt; scale runs from 1 to 5, with 1 being the least aggressive form of cancer. &lt;br /&gt;&lt;br /&gt;The Gleason scores may be helpful in determining which is the best treatment option. Once grading of the cancer has been completed, the next step is to define the stage of the cancer. This basically determines if the cancer has spread and how far the spread has occurred.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/3375717584933337991/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/grading-of-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3375717584933337991'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/3375717584933337991'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/grading-of-prostate-cancer.html' title='Grading of Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-6918796202092639571</id><published>2009-02-19T14:27:00.000-08:00</published><updated>2009-02-19T14:29:19.121-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="prostate biopsy"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate exam"/><category scheme="http://www.blogger.com/atom/ns#" term="PSA test"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal exam"/><title type='text'>Screening and Diagnosis of Prostate Cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Screening tests&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Since Prostate cancer does not cause symptoms in the early stage, the following &lt;span style=&quot;font-weight:bold;&quot;&gt;screening tests&lt;/span&gt; are recommended and include:&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;br /&gt;- Digital rectal exam (DRE&lt;/span&gt;): A digital rectal exam is not fun but essential in examining the prostate. The digital exam can discover the presence of any abnormalities in the texture, shape or size of your gland.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Prostate-specific antigen (PSA)&lt;/span&gt; test: This blood test analyzes the levels of a chemical released from the prostate. Higher levels are not always specific for prostate cancer because infection, inflammation or prostate enlargement may also cause an increase in this chemical.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Transrectal ultrasound&lt;/span&gt;: If the above tests raise any suspicion of prostate cancer, a small probe is placed through the rectum and the gland is analyzed. The images can reveal the presence of any mass or deformity of the gland.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Prostate biopsy&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;If there is suspicion that a mass may be present, a &lt;span style=&quot;font-weight:bold;&quot;&gt;prostate biopsy&lt;/span&gt; is the next step. The biopsy is done under ultrasound guidance. The ultrasound probe is placed through the rectum and will identify any abnormal areas. &lt;br /&gt;&lt;br /&gt;A &lt;span style=&quot;font-weight:bold;&quot;&gt;fine needle&lt;/span&gt; is then inserted for a biopsy. There is minimal pain associated with the test. The tissue specimen is analyzed by the pathologist and the grade of the tumor is determined.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/6918796202092639571/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/screening-and-diagnosis-of-prostate.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6918796202092639571'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6918796202092639571'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/screening-and-diagnosis-of-prostate.html' title='Screening and Diagnosis of Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-8177897627131744529</id><published>2009-02-19T14:25:00.000-08:00</published><updated>2009-02-19T14:27:29.558-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="bloody urine"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate antigen"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate cancer symptoms"/><category scheme="http://www.blogger.com/atom/ns#" term="PSA test"/><category scheme="http://www.blogger.com/atom/ns#" term="urination"/><title type='text'>Symptoms of Prostate Cancer</title><content type='html'>In the early stage of prostate cancer, most individuals have &lt;span style=&quot;font-weight:bold;&quot;&gt;no symptoms&lt;/span&gt;. However, when the &lt;span style=&quot;font-weight:bold;&quot;&gt;cancer grows&lt;/span&gt; or spreads, the individual may present with a weak urine flow, &lt;span style=&quot;font-weight:bold;&quot;&gt;frequent urination &lt;/span&gt;at night or blood in the urine. &lt;br /&gt;&lt;br /&gt;Other rare features may include &lt;span style=&quot;font-weight:bold;&quot;&gt;pain on urination&lt;/span&gt; or pain the lower back.&lt;br /&gt;&lt;br /&gt;Unfortunately there are &lt;span style=&quot;font-weight:bold;&quot;&gt;no early signs or symptoms &lt;/span&gt;of prostate cancer. &lt;br /&gt;&lt;br /&gt;The &lt;span style=&quot;font-weight:bold;&quot;&gt;general advice &lt;/span&gt;is that if one is 50 or older, one should undergo prostate cancer screening. &lt;br /&gt;A blood test is also recommended to check for &lt;span style=&quot;font-weight:bold;&quot;&gt;prostate-specific antigen&lt;/span&gt; (PSA) beginning at age 50, or earlier if one has risk factors for cancer. &lt;br /&gt;&lt;br /&gt;A &lt;span style=&quot;font-weight:bold;&quot;&gt;digital rectal exam &lt;/span&gt;as early as age 40 is also advised in individuals with risk factors.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/8177897627131744529/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/symptoms-of-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/8177897627131744529'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/8177897627131744529'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/symptoms-of-prostate-cancer.html' title='Symptoms of Prostate Cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-6384101118221939994</id><published>2009-02-19T14:16:00.000-08:00</published><updated>2009-02-19T14:19:29.721-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="risks prostate cancer"/><category scheme="http://www.blogger.com/atom/ns#" term="vasectomy"/><title type='text'>Risk Factors for prostate cancer</title><content type='html'>&lt;span style=&quot;font-weight:bold;&quot;&gt;Risk factors&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Knowing the risk factors may help to prevent or delay the onset of &lt;span style=&quot;font-weight:bold;&quot;&gt;prostate cancer&lt;/span&gt;. In addition, knowledge about risk factors may also help one undergo early screening. The risk factors identified to cause prostate cancer include:&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;- Age.&lt;/span&gt; As one gets old, the chances of having prostate cancer increase. It is recommended that after age 50, men should have regular prostate evaluation.&lt;br /&gt;&lt;br /&gt;- &lt;span style=&quot;font-weight:bold;&quot;&gt;Ethnicity.&lt;/span&gt; Of all ethnic groups, blacks have the highest risk of prostate cancer.&lt;br /&gt;&lt;br /&gt;-&lt;span style=&quot;font-weight:bold;&quot;&gt; Hereditary.&lt;/span&gt; If anyone in the family has prostate cancer, the chance of a family member developing the cancer are greatly increased&lt;br /&gt;&lt;br /&gt;- &lt;span style=&quot;font-weight:bold;&quot;&gt;Nutrition. &lt;/span&gt;A high-fat diet and obesity have been associated with an increase in prostate cancer. It is believed that fat stores are important for production of testosterone, and thus reduction in a fatty diet may reduce the risk of developing prostate cancer.&lt;br /&gt;&lt;br /&gt;- &lt;span style=&quot;font-weight:bold;&quot;&gt;Vasectomy: &lt;/span&gt;Although it has been suggested that vasectomy may be a risk factor for prostate cancer, there is no conclusive evidence to substantiate this fact.&lt;br /&gt;&lt;br /&gt;- &lt;span style=&quot;font-weight:bold;&quot;&gt;High levels of testosterone&lt;/span&gt;. Men who have high levels of testosterone are at high risk for prostate cancer. Long term testosterone treatment has been linked to benign prostate hypertrophy and there is a concern that these individuals should undergo regular screening for &lt;a href=&quot;http://www.flickr.com/photos/23270535@N02/2251310092/&quot;&gt;prostate cancer&lt;/a&gt;.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/6384101118221939994/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/risk-factors-for-prostate-cancer.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6384101118221939994'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/6384101118221939994'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/risk-factors-for-prostate-cancer.html' title='Risk Factors for prostate cancer'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7944553634888906866.post-7989920625389042020</id><published>2009-02-19T14:12:00.000-08:00</published><updated>2009-02-19T14:16:36.189-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="black prostate"/><category scheme="http://www.blogger.com/atom/ns#" term="bladder"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate cancer"/><category scheme="http://www.blogger.com/atom/ns#" term="prostate malignancy"/><title type='text'>Prostate Cancer Part 1</title><content type='html'>All men over the age of 50 are at a risk for &lt;span style=&quot;font-weight:bold;&quot;&gt;prostate cancer.&lt;/span&gt; Although prostate cancer rarely occurs in young males, the disorder is primarily seen in older men and the risk of prostate cancer increases with age. More than 70% of men over the age of 65 are annually diagnosed with prostate cancer.&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.flickr.com/photos/23270535@N02/2250514291/&quot;&gt;Prostate cancer&lt;/a&gt; is the most commonly diagnosed cancer among North American men and accounts for 25% of cancers in men. Epidemiology shows that incidence rates for prostate cancer vary geographically. In North America there are variations in incidence rates within the population: the &lt;span style=&quot;font-weight:bold;&quot;&gt;black population&lt;/span&gt; has a significantly higher rate than the white population and the Asian population have the lowest rate.&lt;br /&gt;&lt;br /&gt;The prostate is a small, &lt;span style=&quot;font-weight:bold;&quot;&gt;&lt;a href=&quot;http://www.flickr.com/photos/hamface/2857563356/&quot;&gt;walnut-shaped&lt;/a&gt;&lt;/span&gt; organ located in the rectal area. It surrounds the base of the bladder through which runs the urethra. The primary function of the prostate is to produce seminal fluid which provides nourishment and transports sperm.&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-weight:bold;&quot;&gt;Prostate cancer&lt;/span&gt; is generally a slow growing tumor and typically starts off in the periphery of the gland. In the early stages, prostate cancer causes no symptoms. However, if left untreated, it can grow and invade adjacent organs and spread to other parts of the body. What causes prostate cancer and why some subtypes behave differently remains unknown. It is believed that a multitude of factors such as heredity, ethnicity, hormones, diet and environment may play a role in the cause of prostate cancer.</content><link rel='replies' type='application/atom+xml' href='http://sbmedexcan.blogspot.com/feeds/7989920625389042020/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/prostate-cancer-part-1.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7989920625389042020'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7944553634888906866/posts/default/7989920625389042020'/><link rel='alternate' type='text/html' href='http://sbmedexcan.blogspot.com/2009/02/prostate-cancer-part-1.html' title='Prostate Cancer Part 1'/><author><name>Sbmedex</name><uri>http://www.blogger.com/profile/17918480920297163723</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>